Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 4, 2025
Canadian Pet Population Survey Highlights the Importance of Access to Veterinary Care
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- The latest findings from the 2024 Canadian Pet Population Survey reveal significant insights into the pet ownership landscape in Canada. Conducted by Léger, a leading Canadian research and analytics firm, the …
Le sondage sur la population des animaux de compagnie au Canada souligne l’importance de l’accès aux soins vétérinaires
GlobeNewswire
·
April 4, 2025
TORONTO, 04 avr. 2025 (GLOBE NEWSWIRE) -- Les derniers résultats du sondage sur la population canadienne des animaux de compagnie 2024 révèlent des informations importantes sur les propriétaires d’animaux de compagnie au Canada. Mené par Léger, une firme …
Teleglobal Strengthens Cloud & IT Evolution with AI-Driven Innovations
EIN Presswire
·
April 4, 2025
Teleglobal, a trusted provider of cloud consultancy and IT solutions, is strengthening its position as a leader in cloud sols, RIM, and AI-driven optimizations. PUNE, MAHARASHTRA, INDIA, April 4, 2025 /EINPresswire.com/ -- Teleglobal International, a …
Bispecific Trispecific Antibodies Market Size FDA Approval Clinical Trials Drug Sales Insight 2030
GlobeNewswire
·
April 4, 2025
Delhi, April 04, 2025 (GLOBE NEWSWIRE) -- Over the last two decades, immunotherapy has transformed treatment strategies across various medical fields. The effectiveness of monoclonal antibodies in specifically targeting certain antigens has led to the …
Energetic Harmony Expands Holistic Stress Relief Services with Emotion Code for Professionals Facing Chronic Stress or Past Trauma
GlobeNewswire
·
April 4, 2025
TAMPA BAY, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Energetic Harmony℠, a leader in holistic stress relief, proudly announces the expansion of its services to include Emotion Code—a powerful modality specifically designed to help age 30+ professionals …
Better Choice Company Chairman Provides Shareholder Update on SRx Health Acquisition and Comments on Recent Debt-to-Equity Transaction
GlobeNewswire
·
April 4, 2025
TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, Chairman, Michael Young, today provides shareholders with a update on its SRx Health …
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
GlobeNewswire
·
April 4, 2025
LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update regarding its Definitive …
Medical Filtration Market worth $9.35 billion by 2030, at a 6.8%, says MarketsandMarkets™
GlobeNewswire
·
April 4, 2025
Delray Beach, FL, April 04, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Medical Filtration Market Is projected to reach USD 9.35 billion by 2030 at a CAGR of 6.8%, as per the recent study by MarketsandMarkets™. The combination of regulatory frameworks, …
NurExone Biologic Announces U.S. Uplisting Intention and Closes C$2.3 Million Private Placement
GlobeNewswire
·
April 4, 2025
TORONTO and HAIFA, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX, OTCQB: NRXBF, Germany: J90) (“NurExone” or the “Company”) is pleased to announce that, subject to TSX Venture Exchange (“TSXV”) approval, it has closed a non- …
Better Choice Company Signs Definitive Agreement for SRx Health Solutions to Convert CAD$4 Million in Debt to Equity
GlobeNewswire
·
April 4, 2025
TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce that SRx Health Solutions, Inc. (“SRx Health”) has signed a …
Dental Equipment Market worth US$9.3 Billion by 2029 driven by Specialized Dental Equipment | MarketsandMarkets™.
GlobeNewswire
·
April 4, 2025
Delray Beach, FL, April 04, 2025 (GLOBE NEWSWIRE) -- The global dental equipment market , valued at US$6.5 billion in 2023, is forecasted to grow at a robust CAGR of 6.2%, reaching US$6.9 billion in 2024 and an impressive US$9.3 billion by 2029. The dental …
Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose
GlobeNewswire
·
April 4, 2025
Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq®) The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg in combination with atezolizumab in patients with platinum-resistant …
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
GlobeNewswire
·
April 4, 2025
Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology meeting Long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in focal onset seizures (FOS) Exploratory analysis of efficacy of …
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
GlobeNewswire
·
April 4, 2025
EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological …
Entourage Health Corp. Announces Closing of Plan of Arrangement
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (the “Company” or “Entourage”) is pleased to announce the closing of the previously announced plan of arrangement (the “Arrangement”) pursuant to …
Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory …
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
GlobeNewswire
·
April 4, 2025
PALO ALTO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
DALLAS, April 04, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of …
EluPro™ Named as 2025 Edison Award Winner
GlobeNewswire
·
April 4, 2025
Innovative Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Pacemakers and Neurostimulators Earns Bronze in Post-Surgical Recovery Solutions Category SILVER SPRING, Md., April 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia …
Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 4, 2025
WAYNE, Pa., April 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare …